Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

2.090 USD -0.140 (-6.28%)
Official Closing Price Updated: 7:43 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adma Biologics

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
25 Stocks Moving In Monday's Pre-Market Session
Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 23.6% to $0.26 in pre-market trading after receiving an approval ... 
Tags SE XBIO NTRA
From Benzinga
29 Healthcare Stocks Moving In Friday's After-Market Session
Gainers ADMA Biologics, Inc. (NASDAQ: ADMA) shares surged 13.2% to $3.94 during Friday's after-market session. The market ... 
Tags SNDL NVAX LPTX
From Benzinga
Top Buys by Top Brass: CEO Grossman's $120K Bet on ADMA
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider... 
Tags Stocks
From Market News Video
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
All Aspects of the Biotest Therapy Business Unit (“BTBU”) Acquisition Are Successfully Completed 
From GlobeNewswire News Releases
Interesting ADMA Put And Call Options For February 2020
Investors in ADMA Biologics Inc (ADMA) saw new options become available this week, for the February 2020 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
Look Under The Hood: VTWO Has 15% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
NASDAQ:ADMA Investor Alert: Investigation over Potential Wrongdoing at ADMA Biologics, Inc.
San Diego, CA -- (SBWIRE) -- 06/20/2019 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at ADMA Biologics, Inc. 
From SBWire - Latest Press Releases
31 Stocks Moving In Tuesday's Pre-Market Session
Gainers ADMA Biologics, Inc. (NASDAQ: ADMA) rose 24.4 percent to $4.69 in pre-market trading. Motus GI Holdings, Inc. (NASDAQ: ... 
Tags ONCT ZYNE SYMC
From Benzinga
55 Biggest Movers From Yesterday
Gainers La Jolla Pharmaceutical Company (NASDAQ: LJPC) jumped 92.48 percent to close at $10.24 on Thursday after the company's ... 
Tags GRVY SAIC VRA
From Benzinga
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of ADMA Biologics, Inc. -- ADMA
Levi & Korsinsky announces it has commenced an investigation of ADMA Biologics, Inc. (NASDAQ: ADMA) concerning possible breaches of fiduciary duty. To obtain additional information, go to: 
From GlobeNewswire News Releases
42 Stocks Moving In Thursday's Mid-Day Session
Gainers ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) shares jumped 133 percent to $11.65 after the company showed results from ... 
Tags KOOL GRFS AMD
From Benzinga
Investors Grab ADMA Even Cheaper Than Its Secondary Stock Offering
Looking back to 20 days ago, ADMA Biologics Inc (ADMA) priced a 11,250,000 share secondary stock offering at $4.00 per share. Buyers in that offering made a considerable investment into the company,... 
Tags Stocks
From Market News Video
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ADMA Biologics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of... 
From PR Newswire
Benzinga's Top Upgrades, Downgrades For June 4, 2019
Top Upgrades BMO Capital upgraded Take-Two Interactive Inc (NASDAQ: TTWO) from Underperform to Market Perform. Take-Two shares ... 
Tags Benzinga ADMA GOOGL
From Benzinga
ADMA Biologics to Present at Upcoming Investor Conferences
ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops... 
From GlobeNewswire News Releases
ADMA Biologics (ADMA) Shares Cross Above 200 DMA
In trading on Wednesday, shares of ADMA Biologics Inc (ADMA) crossed above their 200 day moving average of $4.72, changing hands as high as $4.74 per share. ADMA Biologics Inc shares are currently... 
Tags Stocks
From Market News Video
28 Stocks Moving In Wednesday's Pre-Market Session
Gainers Valeritas Holdings, Inc. (NASDAQ: VLRX) shares rose 35.3 percent to $5.10 in pre-market trading following news it will ... 
Tags PLAB NEO NE
From Benzinga
ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops specialty... 
From GlobeNewswire News Releases
How The Pieces Add Up: IWO Targets $237
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags FDA FATE AXSM
From Benzinga
ADMA Biologics Announces Pricing of Public Offering of Common Stock
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops specialty... 
From GlobeNewswire News Releases
63 Biggest Movers From Yesterday
Gainers Jiayin Group Inc. (NASDAQ: JFIN) shares rose 56.1 percent to close at $21.70 on Thursday. Iovance Biotherapeutics, Inc. ... 
Tags Benzinga TAIT JFIN
From Benzinga
50 Stocks Moving In Thursday's Mid-Day Session
Gainers Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) jumped 34.2 percent to $15.06. Iovance Biotherapeutics announced new interim ... 
Tags FTSI Markets NTES
From Benzinga
30 Stocks Moving In Thursday's Pre-Market Session
Gainers Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) rose 26.9 percent to $14.25 after the company issued updates to tumor ... 
Tags Top Gainers GNW SRAX
From Benzinga
NeuBase Therapeutics Designates Industry Leaders to Board of Directors
Board members bring decades of executive experience in successful commercialization of pharmaceuticals to NeuBase 
From GlobeNewswire News Releases
The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags AMRX SILK AXSM
From Benzinga
7 Stocks To Watch For May 16, 2019
Some of the stocks that may grab investor focus today are: Wall Street expects Walmart Inc. (NYSE: WMT) to report quarterly ... 
Tags Earnings AZZ NVDA
From Benzinga
6 Stocks Moving In Wednesday's After-Hours Session
Gainers Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares are up 10 percent after reporting its Phase 3 ClarIDHy trial of TIBSOVO ... 
Tags CSCO News Benzinga
From Benzinga
ADMA Biologics Announces Proposed $45 Million Public Offering of Common Stock
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops specialty... 
From GlobeNewswire News Releases
FDA Approves Prior Approval Supplement for BIVIGAM®
ADMA Announces it will Commence Commercial Sales of BIVIGAM® 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.